Cargando…

Different patterns of HIV-1 DNA after therapy discontinuation

BACKGROUND: By persisting in infected cells for a long period of time, proviral HIV-1 DNA can represent an alternative viral marker to RNA viral load during the follow-up of HIV-1 infected individuals. In the present study sequential blood samples of 10 patients under antiretroviral treatment from 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Re, Maria Carla, Vitone, Francesca, Sighinolfi, Laura, Schiavone, Pasqua, Ghinelli, Florio, Gibellini, Davide
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236926/
https://www.ncbi.nlm.nih.gov/pubmed/16156892
http://dx.doi.org/10.1186/1471-2334-5-69
_version_ 1782125010721177600
author Re, Maria Carla
Vitone, Francesca
Sighinolfi, Laura
Schiavone, Pasqua
Ghinelli, Florio
Gibellini, Davide
author_facet Re, Maria Carla
Vitone, Francesca
Sighinolfi, Laura
Schiavone, Pasqua
Ghinelli, Florio
Gibellini, Davide
author_sort Re, Maria Carla
collection PubMed
description BACKGROUND: By persisting in infected cells for a long period of time, proviral HIV-1 DNA can represent an alternative viral marker to RNA viral load during the follow-up of HIV-1 infected individuals. In the present study sequential blood samples of 10 patients under antiretroviral treatment from 1997 with two NRTIs, who refused to continue any antiviral regimen, were analyzed for 16 – 24 weeks to study the possible relationship between DNA and RNA viral load. METHODS: The amount of proviral DNA was quantified by SYBR green real-time PCR in peripheral blood mononuclear cells from a selected group of ten patients with different levels of plasmatic viremia (RNA viral load). RESULTS: Variable levels of proviral DNA were found without any significant correlation between proviral load and plasma HIV-1 RNA levels. Results obtained showed an increase or a rebound in viral DNA in most patients, suggesting that the absence of therapy reflects an increase and/or a persistence of cells containing viral DNA. CONCLUSION: Even though plasma HIV RNA levels remain the basic parameter to monitor the intensity of viral replication, the results obtained seem to indicate that DNA levels could represent an adjunct prognostic marker in monitoring HIV-1 infected subjects.
format Text
id pubmed-1236926
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12369262005-09-29 Different patterns of HIV-1 DNA after therapy discontinuation Re, Maria Carla Vitone, Francesca Sighinolfi, Laura Schiavone, Pasqua Ghinelli, Florio Gibellini, Davide BMC Infect Dis Research Article BACKGROUND: By persisting in infected cells for a long period of time, proviral HIV-1 DNA can represent an alternative viral marker to RNA viral load during the follow-up of HIV-1 infected individuals. In the present study sequential blood samples of 10 patients under antiretroviral treatment from 1997 with two NRTIs, who refused to continue any antiviral regimen, were analyzed for 16 – 24 weeks to study the possible relationship between DNA and RNA viral load. METHODS: The amount of proviral DNA was quantified by SYBR green real-time PCR in peripheral blood mononuclear cells from a selected group of ten patients with different levels of plasmatic viremia (RNA viral load). RESULTS: Variable levels of proviral DNA were found without any significant correlation between proviral load and plasma HIV-1 RNA levels. Results obtained showed an increase or a rebound in viral DNA in most patients, suggesting that the absence of therapy reflects an increase and/or a persistence of cells containing viral DNA. CONCLUSION: Even though plasma HIV RNA levels remain the basic parameter to monitor the intensity of viral replication, the results obtained seem to indicate that DNA levels could represent an adjunct prognostic marker in monitoring HIV-1 infected subjects. BioMed Central 2005-09-12 /pmc/articles/PMC1236926/ /pubmed/16156892 http://dx.doi.org/10.1186/1471-2334-5-69 Text en Copyright © 2005 Carla Re et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Re, Maria Carla
Vitone, Francesca
Sighinolfi, Laura
Schiavone, Pasqua
Ghinelli, Florio
Gibellini, Davide
Different patterns of HIV-1 DNA after therapy discontinuation
title Different patterns of HIV-1 DNA after therapy discontinuation
title_full Different patterns of HIV-1 DNA after therapy discontinuation
title_fullStr Different patterns of HIV-1 DNA after therapy discontinuation
title_full_unstemmed Different patterns of HIV-1 DNA after therapy discontinuation
title_short Different patterns of HIV-1 DNA after therapy discontinuation
title_sort different patterns of hiv-1 dna after therapy discontinuation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236926/
https://www.ncbi.nlm.nih.gov/pubmed/16156892
http://dx.doi.org/10.1186/1471-2334-5-69
work_keys_str_mv AT remariacarla differentpatternsofhiv1dnaaftertherapydiscontinuation
AT vitonefrancesca differentpatternsofhiv1dnaaftertherapydiscontinuation
AT sighinolfilaura differentpatternsofhiv1dnaaftertherapydiscontinuation
AT schiavonepasqua differentpatternsofhiv1dnaaftertherapydiscontinuation
AT ghinelliflorio differentpatternsofhiv1dnaaftertherapydiscontinuation
AT gibellinidavide differentpatternsofhiv1dnaaftertherapydiscontinuation